Select Page

Our latest research report entitled Drug Eluting Balloon Market (by product type (peripheral drug-eluting balloon, coronary drug eluting balloon, and others), end-user (cath labs, hospitals, ambulatory surgery centers, and others), coating technology (enduracoat, freepac, paccocath, transpax, and others)) provides complete and deep insights into the market dynamics and growth of drug eluting balloon. The latest information on market risks, industry chain structure drug eluting balloon cost structure and opportunities are offered in this report. The past, present and forecast market information will lead to investment feasibility by studying the essential drug-eluting balloon growth factors. According to the report, the global drug-eluting balloon market is projected to grow at a CAGR of 19% over the forecast period of 2018-2024.

We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report:

Drug-eluting balloons (DEB) are a conservative semi-compliant angioplasty balloon that is covered with an anti-proliferative drug. The (DE) balloon is inserted into the blocked artery and left for a few minutes. The drug is discharged into the vessel wall at the time of inflation of the balloon, and at minimal pressures with a minimal inflation time. Minor surgeries and open-heart surgeries can be threatening to life as they contain numerous difficulties. The surgeon adopts MI techniques over traditional techniques as they assure faster recovery, reduced hospital stays negligible obstacles and high accuracy. Drug-eluting balloons also play an important role in the treatment of coronary artery disease.

Growing Geriatric Population and Rising Incidence of Peripheral Artery Diseases (PAD) Worldwide are Major Factors Driving the Growth for Drug-Eluting Balloon Market

The growing geriatric population and rising incidence of peripheral artery diseases (PAD) worldwide are major factors driving the growth for drug-eluting balloon industry. Coronary artery disease occurs when the arteries that supply blood to the heart muscle become narrow or hard owing to the accumulation of cholesterol and other resources on the inner walls. Hence, this results in deficient oxygen and blood flow and can lead to chest pain or heart attack. Coronary artery diseases also fail the heart muscle and can lead to heart failure and arrhythmias thus, the growing prevalence for coronary artery diseases is another factor driving the growth of the market. Besides, Drug-eluting balloon is gaining acceptance amongst surgeons, as they are effective for the treatment of peripheral artery and coronary artery diseases.

This balloon decreases the risk of stent failure is more effective in the treatment of superficial femoral artery (SFA). Increase in R&D activities supported by government policies is anticipated to generate an opportunity for coming years. On the other side, long-governing approval procedure, and major investment required owing to the high erosion rate in clinical trials are likely to hamper the market growth for drug-eluting balloon market.

Get this Section as a Free Customization in the Report along with 30% Discount on the Study:

“We have Decided to Extend our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Global on Drug Eluting Balloon Market Amidst COVID-19.”

North America Holds the Significant Share in Drug-Eluting Balloon Market

Among the geographies, North America holds a significant share in the drug-eluting balloon market. Owing to increasing awareness regarding therapeutic applications of drug-eluting balloons in coronary and peripheral artery diseases is driving the growth of the drug-eluting balloon industry in North America region. Additionally, augmented investments by several foreign medical device companies have also pushed the growth of the drug-eluting balloons market in this region.

Drug Eluting Balloon Market: Segmentation

The report on global drug-eluting balloon market covers segments such as product type, end-user, and coating technology. On the basis of product type, the sub-markets include peripheral drug eluting balloon, coronary drug eluting balloon, and others. On the basis of end-user, the sub-markets include cath labs, hospitals, ambulatory surgery centers, and others. On the basis of coating technology, the sub-markets include enduracoat, freepac, paccocath, transpax, and others.

Browse Detailed TOC, Description, and Companies Mentioned in Report @

Key Players in the Drug-Eluting Balloon Market

The report provides profiles of the companies in the drug-eluting balloon market such as Koninklijke Philips N.V, Eurocor GmbH, Biotronik SE & Co. KG, Boston Scientific Corporation, B. Braun Melsungen AG, Bayer AG, Terumo Corporation, Becton, Dickinson and Company, Cook Medical, Inc., and Medtronic Plc.

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the drug-eluting balloon.
  • Complete coverage of all the product type and application segments to analyze the trends, developments, and forecast of market size up to 2024.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research– Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.